ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmunoGen, Inc. is a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer.
- Go to the previous page
- 1
- …
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- …
- 245
- Go to the next page